Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 6.54
+0.16 (2.51%)
Nov 3, 2025, 2:42 PM CET
Boule Diagnostics AB Market Cap
Boule Diagnostics AB has a market cap or net worth of 251.64 million as of November 3, 2025. Its market cap has decreased by -12.20% in one year.
Market Cap
251.64M
Enterprise Value
436.44M
Revenue
512.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.54
Market Cap Chart
Since June 23, 2011, Boule Diagnostics AB's market cap has increased from 162.45M to 251.64M, an increase of 54.90%. That is a compound annual growth rate of 3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 251.64M | -27.84% |
| Dec 30, 2024 | 348.72M | -19.96% |
| Dec 29, 2023 | 435.71M | -25.70% |
| Dec 30, 2022 | 586.38M | -38.11% |
| Dec 30, 2021 | 947.53M | -17.98% |
| Dec 30, 2020 | 1.16B | -12.76% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 112.77B |
| Getinge AB | 60.82B |
| Sectra AB | 58.15B |
| Medicover AB | 39.10B |
| Camurus AB | 37.23B |
| Asker Healthcare Group AB | 33.00B |
| BioArctic AB | 25.95B |
| AddLife AB | 25.03B |